N6-methyladenine RNA Modification (m6A): An Emerging Regulator of Metabolic Diseases
- PMID: 32066359
- DOI: 10.2174/1389450121666200210125247
N6-methyladenine RNA Modification (m6A): An Emerging Regulator of Metabolic Diseases
Abstract
N6-methyladenine RNA modification (m6A) is an RNA methylation modification catalyzed by methyltransferase at the 6th position nitrogen atom of adenine (A), which is the most common chemical modification of eukaryotic messenger RNA (mRNA). Recently, m6A has been found to play an important role in the dynamic regulation of RNA, which is crucial for some physiological and pathophysiological processes such as adipogenesis, cell differentiation, and the immune/inflammatory response. Metabolic diseases are a series of chronic inflammatory disorders caused by metabolic dysfunction of proteins, glucose, and lipids. Emerging studies have shown that m6A plays an important role in the process of metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVDs) via regulation of glucose/lipid metabolism and the immune/inflammatory response. In this review, we will summarize the role of m6A in metabolic diseases, which may provide new ideas for the prevention and treatment of metabolic diseases.
Keywords: N6-adenine methylation; cardiovascular diseases; metabolic diseases; obesity; type 2 diabetes mellitus.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
N6-Adenosine Methylation (m6A) RNA Modification: an Emerging Role in Cardiovascular Diseases.J Cardiovasc Transl Res. 2021 Oct;14(5):857-872. doi: 10.1007/s12265-021-10108-w. Epub 2021 Feb 25. J Cardiovasc Transl Res. 2021. PMID: 33630241 Review.
-
Insights into RNA N6-methyladenosine in Glucose and Lipid Metabolic Diseases and Their Therapeutic Strategies.Endocrinology. 2023 Nov 20;165(1):bqad170. doi: 10.1210/endocr/bqad170. Endocrinology. 2023. PMID: 37950364 Review.
-
Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.Cells. 2022 Mar 24;11(7):1101. doi: 10.3390/cells11071101. Cells. 2022. PMID: 35406663 Free PMC article. Review.
-
Role of DNA and RNA N6-Adenine Methylation in Regulating Stem Cell Fate.Curr Stem Cell Res Ther. 2018;13(1):31-38. doi: 10.2174/1574888X12666170621125457. Curr Stem Cell Res Ther. 2018. PMID: 28637404 Review.
-
A Review in Research Progress Concerning m6A Methylation and Immunoregulation.Front Immunol. 2019 Apr 26;10:922. doi: 10.3389/fimmu.2019.00922. eCollection 2019. Front Immunol. 2019. PMID: 31080453 Free PMC article. Review.
Cited by
-
Identification of genes related to fatty acid metabolism in type 2 diabetes mellitus.Biochem Biophys Rep. 2024 Oct 22;40:101849. doi: 10.1016/j.bbrep.2024.101849. eCollection 2024 Dec. Biochem Biophys Rep. 2024. PMID: 39498440 Free PMC article.
-
The regulatory role of m6A methylation modification in metabolic syndrome pathogenesis and progression.Front Physiol. 2024 Mar 14;15:1271874. doi: 10.3389/fphys.2024.1271874. eCollection 2024. Front Physiol. 2024. PMID: 38562618 Free PMC article. Review.
-
Glucocorticoid Regulates the Synthesis of Porcine Muscle Protein through m6A Modified Amino Acid Transporter SLC7A7.Int J Mol Sci. 2022 Jan 10;23(2):661. doi: 10.3390/ijms23020661. Int J Mol Sci. 2022. PMID: 35054897 Free PMC article.
-
The role of RNA m6A methylation in lipid metabolism.Front Endocrinol (Lausanne). 2022 Sep 8;13:866116. doi: 10.3389/fendo.2022.866116. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36157445 Free PMC article. Review.
-
Biological networks in gestational diabetes mellitus: insights into the mechanism of crosstalk between long non-coding RNA and N6-methyladenine modification.BMC Pregnancy Childbirth. 2022 May 3;22(1):384. doi: 10.1186/s12884-022-04716-w. BMC Pregnancy Childbirth. 2022. PMID: 35505296 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
